| Acceptance rate | 46% |
|---|---|
| Time to first decision | 6 months* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2018 , Vol 56 , Num 4
Pharmacological and Pharmaceutical Technological Overview for Seborrheic Dermatitis: A Review About Topical Application and New Approaches
1 Anadolu University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Eskişehir, TurkeyDOI : 10.23893/1307-2080.APS.05626 Viewed : 15445 - Downloaded : 6956 Seborrheic dermatitis (SD) is a skin disease with chronic recurrent erythematous plaques in areas where sebaceous glands are intense. The etiology of SD remains unknown, although many factors such as lipophilic yeasts of the Malassezia genus, hormones, genetic, environmental and general health factors have been shown to be causative. SD is affecting body parts involving rich sebaceous glands such as head and skin. Treatment options include application of anti-inflammatory, antifungal, keratolytic, and sebosupressive agents. The SD causes are briefly mentioned in this review. Then, detailed information was given about the medicines used in SD treatment. The most important element of this article is to be used in SD treatment; new approaches such as new formulations, new active substances and narrow band UV rays have been mentioned. Finally, some examples of the Pharmacist"s role in SD treatment in general are given. Keywords : Seborrheic dermatitis; Formulation; Topical applications